A Big Step for CRISPR-Based SARS-CoV-2 Test by Glenn S. Demby | Jan 31, 2022 | Articles, Essential, FDA-lir, Laboratory Industry Report... Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here
Agency Continues Crack Down on Unauthorized COVID-19 Tests by Glenn S. Demby | Jan 19, 2022 | Articles, Clinical Diagnostics Insider, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet, Recent HeadlinesOn Jan. 11, the FDA warned consumers not to use COVID-19 tests from LuSys Laboratories, as they have not been approved for use in the US. Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here
Agency Unveils Guidance for Full Approval of SARS-CoV-2 Tests by Glenn S. Demby | Jan 7, 2022 | Articles, Essential, FDA-lir, Laboratory Industry Report... Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here
Device Reclassification Order Opens 510(k) Pathway for HCV RNA and Antibodies Tests by Glenn S. Demby | Dec 16, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here
Agency Regains Its Authority to Regulate Laboratory Developed Tests (LDTs) by Glenn S. Demby | Nov 29, 2021 | Articles, Clinical Diagnostics Insider, Coronavirus, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet... Subscribe to View Start a Free Trial for immediate access to this article Try For FreeAlready a member? Log in here